A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

NCT01466725 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped The benefit/risk profile does not support continuation of this study.

Conditions

Interventions

Sponsor

Celgene